Follikuláris limfóma: vizsgálatok itt: Tajvan
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Where
- Taipei, Taoyuan
- Életkor
- 18 év and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00 - 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Changhua, Kaohsiung City, Lukang Township, Tainan, Taipei
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Kaohsiung City, Taichung, Tainan, Taipei
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - No phaseTaking peopleLong-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
- Where
- Kaohsiung, Tainan, Taipei
- People
- 49
- Run by
- Pell Bio-Med Technology Co., Ltd.
See details and how to joinNCT05377307 - 3. fázisTaking peopleA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Buzi, Changhua, Kaohsiung City, New Taipei City, Tainan, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00 - 3. fázisTaking peopleA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Buzi, Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00 - 1. fázisTaking peopleA Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies
- Where
- Taipei
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- GenomeFrontier Therapeutics TW Co., Ltd.
See details and how to joinNCT06703892 - No phaseCsak meghívásosLong-term Study to Evaluate Safety and Persistence of GF-CART01
- Where
- Taipei
- People
- 18
- Run by
- GenomeFrontier Therapeutics TW Co., Ltd.
See details and how to joinNCT06985576